A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Report of the Veterans Administration and National Institute of Mental Health collaborative study group.
D000328:Adult; D000342:Affective Symptoms / Q000188:drug therapy; D001714:Bipolar Disorder / Q000188:drug therapy; D002254:Carbonates; D002746:Chlorpromazine / Q000009:adverse effects / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006760:Hospitalization; D006787:Hospitals, Veterans; D006801:Humans; D008094:Lithium / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D011569:Psychiatric Status Rating Scales; D011605:Psychoses, Substance-Induced / Q000139:chemically induced; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D014987:Xerostomia / Q000139:chemically induced
D002254:Carbonates; D008094:Lithium; D002746:Chlorpromazine